JNJ

172.25

-0.87%↓

ABBV

197.81

+0.43%↑

AZN

74.88

+1.44%↑

NVS

119.07

+1.22%↑

ABT

130.51

-0.63%↓

JNJ

172.25

-0.87%↓

ABBV

197.81

+0.43%↑

AZN

74.88

+1.44%↑

NVS

119.07

+1.22%↑

ABT

130.51

-0.63%↓

JNJ

172.25

-0.87%↓

ABBV

197.81

+0.43%↑

AZN

74.88

+1.44%↑

NVS

119.07

+1.22%↑

ABT

130.51

-0.63%↓

JNJ

172.25

-0.87%↓

ABBV

197.81

+0.43%↑

AZN

74.88

+1.44%↑

NVS

119.07

+1.22%↑

ABT

130.51

-0.63%↓

JNJ

172.25

-0.87%↓

ABBV

197.81

+0.43%↑

AZN

74.88

+1.44%↑

NVS

119.07

+1.22%↑

ABT

130.51

-0.63%↓

Search

AngioDynamics Inc

Ouvert

SecteurSoins de santé

8.64 2.13

Résumé

Variation du prix de l'action

24h

Actuel

Min

8.37

Max

8.67

Chiffres clés

By Trading Economics

Revenu

-1.6M

-6.1M

Ventes

8.2M

80M

BPA

-0.03

Marge bénéficiaire

-7.548

Employés

675

EBITDA

52K

-277K

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+98.22% upside

Dividendes

By Dow Jones

Prochains Résultats

2 oct. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-39M

353M

Ouverture précédente

6.51

Clôture précédente

8.64

Sentiment de l'Actualité

By Acuity

50%

50%

162 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bearish Evidence

AngioDynamics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

9 déc. 2024, 15:23 UTC

Principaux Mouvements du Marché

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

9 déc. 2024, 15:20 UTC

Principaux Mouvements du Marché

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

Comparaison

Variation de prix

AngioDynamics Inc prévision

Objectif de Prix

By TipRanks

98.22% hausse

Prévisions sur 12 Mois

Moyen 16.75 USD  98.22%

Haut 24 USD

Bas 10 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

4 ratings

3

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

9 / 9.3Support & Résistance

Court Terme

Bearish Evidence

Moyen Terme

Very Strong Bearish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

162 / 374Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.